Abstract
Purpose
The diagnosis and management of adrenocorticotropic hormone-independent Cushing’s syndrome (AICS) with bilateral adrenal lesions remain challenging. Some studies have explored the value of adrenal vein sampling (AVS) in patients with AICS; however, more investigations are needed to assess its benefits for diagnosis and treatment planning in this population.
Methods
Thirteen patients with clinical, biochemical and imaging evidence of AICS with bilateral adrenal lesions underwent AVS in our department from 2017–2022 were recruited. Only the data from nine patients for whom AVS succeeded were finally included in this study and further analyzed. Blood samples were successfully collected from both adrenal veins (AV) and inferior vena cava (IVC) in these nine patients, and the levels of plasma total cortisol (PTC) and plasma aldosterone concentrations (PAC) were measured. The ratio of the PAC of the AV to the IVC was calculated, and the PTC to PAC ratios were compared between AV. The surgical strategy was chosen according to the results of AVS. Postoperative histology and immunohistochemistry of the adrenal tissues were performed. The prognosis was evaluated based on the improvement of clinical symptoms and biochemical parameters (including PTC and ACTH measurements).
Results
Patients with AICS were clinically diagnosed based on clinical signs, results of functional tests and the presence of bilateral adrenal lesions as observed on computed tomography imaging. An AV to IVC PAC ratio greater than 2 confirmed successful AVS. The PTC to PAC ratio (high side to low side) was greater than 2 in four patients, and less than 2 in five patients. The postoperative pathological results were consistent with clinical diagnosis and AVS. During the mean follow-up of 33 months, all nine patients achieved varying degrees of clinical improvement.
Conclusion
Our study showed that AVS helped to distinguish unilateral and bilateral lesions, identify the laterality of the autonomous hypercortisolism, and improve therapeutic strategy selection in patients with AICS and bilateral adrenal lesions.
Similar content being viewed by others
References
A. Lacroix, R.A. Feelders, C.A. Stratakis, L.K. Nieman, Cushing’s syndrome. Lancet 386, 913–927 (2015)
A. Lacroix, I. Bourdeau, Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol. Metab. Clin. North Am. 34, 441–458 (2005). x
I. Bourdeau, N. El Ghorayeb, N. Gagnon, A. Lacroix, MANAGEMENT OF ENDOCRINE DISEASE: Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas. Eur. J. Endocrinol. 179, R57–r67 (2018)
Stratakis CA. Cushing Syndrome Caused by Adrenocortical Tumors and Hyperplasias (Corticotropin- Independent Cushing Syndrome).
W.F. Young Jr, H. du Plessis, G.B. Thompson, C.S. Grant, D.R. Farley, M.L. Richards, D. Erickson, A. Vella, A.W. Stanson, J.A. Carney, C.F. Abboud, P.C. Carpenter, The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J. Surg. 32, 856–862 (2008)
J. Wei, S. Li, Q. Liu, Y. Zhu, N. Wu, Y. Tang, Q. Li, K. Ren, Q. Zhang, Y. Yu, Z. An, J. Chen, J. Li, ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures. BMC Endocr. Disord. 18, 22 (2018)
P. Raje, J.M. Broekhuis, B.A. Sacks, B.C. James, Diagnostic Impact of Adrenal Vein Sampling in Adrenal Cushing’s Syndrome. J. Surg. Res. 268, 660–666 (2021)
X. An, G. Liao, Y. Chen, A. Luo, J. Liu, Y. Yuan, L. Li, L. Yang, H. Wang, F. Liu, G. Yang, S. Yi, Y. Li, J. Cheng, Y. Lu, Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model. Stem Cell Res Ther. 10, 363 (2019)
Y. Nakamura, M. Kitada, F. Satoh, T. Maekawa, R. Morimoto, Y. Yamazaki, K. Ise, C.E. Gomez-Sanchez, S. Ito, Y. Arai, M. Dezawa, H. Sasano, Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17. Mol. Cell Endocrinol. 422, 57–63 (2016)
L. Sun, Y. Jiang, J. Xie, H. Zhu, L. Wu, X. Zhong, W. Zhou, T. Su, W. Wang, Immunohistochemical Analysis of CYP11B2, CYP11B1 and β-catenin Helps Subtyping and Relates With Clinical Characteristics of Unilateral Primary Aldosteronism. Front Mol. Biosci. 8, 751770 (2021)
L.K. Nieman, B.M. Biller, J.W. Findling, M.H. Murad, J. Newell-Price, M.O. Savage, A. Tabarin, Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 100, 2807–2831 (2015)
G. Rubinstein, A. Osswald, L.T. Braun, F. Vogel, M. Kroiss, S. Pilz, S. Deniz, L. Aigner, T. Knösel, J. Bertherat, L. Bouys, R. Ladurner, A. Riester, M. Bidlingmaier, F. Beuschlein, M. Reincke, The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients. Endocrine. 76, 434–445 (2022)
R.G. Martins, R. Agrawal, D.M. Berney, R. Reznek, M. Matson, A.B. Grossman, M.R. Druce, Differential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous sampling. Endocr. Pr. 18, e153–157 (2012)
W.F. Young, A.W. Stanson. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clinical Endocrinol. 70, 14–17(2010
D. Patel, S.K. Gara, R.J. Ellis, M. Boufraqech, N. Nilubol, C. Millo, C.A. Stratakis, E. Kebebew, FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization. World J. Surg. 40, 683–689 (2016)
T. Seki, A. Yasuda, N. Kitajima, M. Oki, A. Takagi, N. Nakamura, K. Hanai, T. Terachi, M. Fukagawa, Adrenal Venous Sampling Is Useful for a Definitive Diagnosis in Cushing’s Syndrome with Bilateral Adrenal Tumors. Tokai J. Exp. Clin. Med. 40, 149–156 (2015)
Funding
This work was supported by the National Key Research and Development Program of China (No. 2021YFC2501600, 2021YFC2501601), the Sichuan Science and Technology Program (No. 23ZDYF2116, 23ZDYF2910), and the 1·3·5 project for disciplines of excellence–Clinical Research Incubation Project, West China Hospital, Sichuan University (No. 2021HXFH008).
Author information
Authors and Affiliations
Contributions
Y.R. and T.C. were mainly responsible for research design, and for elucidating the experimental findings derived from AVS investigations. X.A., D.M., T.Z. and J.L. executed the patient recruitment and longitudinal follow-up. Y.Z. was mainly conducted AVS procedures and surgical operations for all patients. S.S. took part in all AVS and surgeries. D.Z. and Y.L. were mainly responsible for data analysis. H.T. provided expert guidance in the realm of clinical diagnosis. L.L. was mainly responsible for immumohistochemical staining and subsequent pathologic diagnose. N.W. took part in AVS procedures of two patients. X.A. wrote the initial manuscript draft. X.A., T.C. and Y.R. revised the manuscript. Y.R. edited and approved the final draft.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of West China Hospital.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
An, X., Chen, T., Mo, D. et al. Role of adrenal venous sampling in the differential diagnosis and treatment protocol of ACTH-independent Cushing’s syndrome with bilateral adrenal lesions. Endocrine 81, 562–572 (2023). https://doi.org/10.1007/s12020-023-03395-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03395-7